Overview
Obligated since award on contracts active FY2021–FY2026
Click a company to open its profile.
Insight NATIONAL INSTITUTES OF HEALTH NIDA (75N950) is its largest buyer. See more on the Buyers tab
About
From the company's SBA profile, updated Feb 2026
Murty Pharmaceuticals, Inc. provides drug formulation development, analytical lab testing, and manufacturing scale up services.
Agencies report with a delay; the latest year will rise
Hover over a year to see its value.
Insight Largest year: $2.93M in FY2002; since FY2021, $872K in FY2021. See more on the Contracts tab
$2.8M since award = $814K in FY2021–FY2026 + $1.99M before FY2021
Click a state to open its page.
Insight 95% was performed in Kentucky. See more on the Contracts tab
Contracts
9 contracts with an action since FY2021
Click a tile to open its contract.
Insight Stand-alone contracts hold 59% of these contracts' obligations.
Click a bar to open its industry page.
Insight 98% under NAICS 541715.
Current end date of each prime contract with an action since FY2021
Hover over a month to see its value.
Murty Pharmaceuticals, Inc. prime contracts with an action in FY2021–FY2026
Find a contract by vehicle, office or end date; sort by money to see the largest.
1 end within 12 months.
Showing 1–9 of 9 contracts
| Since award, US$ | |||||
|---|---|---|---|---|---|
| Parent contract (IDVIDV: the record type for any contract that exists to take orders: IDIQs, GWACs, GSA Schedules, BPAs and basic ordering agreements. Glossary) | ObligatedObligation: money the government has legally committed to a contract. It is not the same as money paid. Example: $6M obligated of a $10M ceiling. Glossary | ||||
| HHSN271201600028C | Stand-alone | NATIONAL INSTITUTES OF HEALTH NIDA (75N950) | $1,644,780 | Oct 30, 2021 | Ended |
| 75N95021F00001 | 75N95021D00024 | NATIONAL INSTITUTES OF HEALTH NIDA (75N950) | $312,612 | Mar 14, 2025 | Ended |
| 75N95023F00001 | 75N95021D00024 | NATIONAL INSTITUTES OF HEALTH NIDA (75N950) | $245,582 | Dec 31, 2025 | Ended |
| 75N95019F00088 | HHSN271201700021I | NATIONAL INSTITUTES OF HEALTH NIDA (75N950) | $145,728 | Mar 14, 2023 | Ended |
| 75N98026F00001 | 75N95021D00024 | NATIONAL INSTITUTES OF HEALTH OLAO (75N980) | $92,724 | Sep 12, 2027 | Ends within 12 months |
| 75N95025F00001 | 75N95021D00024 | NATIONAL INSTITUTES OF HEALTH NIDA (75N950) | $92,724 | Sep 17, 2026 | Ended |
| 75N95024F00001 | 75N95021D00024 | NATIONAL INSTITUTES OF HEALTH NIDA (75N950) | $90,784 | Sep 12, 2025 | Ended |
| 75N95023F00002 | 75N95021D00024 | NATIONAL INSTITUTES OF HEALTH NIDA (75N950) | $90,784 | Sep 12, 2024 | Ended |
| 75N95022F00001 | 75N95021D00024 | NATIONAL INSTITUTES OF HEALTH NIDA (75N950) | $88,415 | Sep 22, 2023 | Ended |
Buyers
National Institutes of Health: $2.8M obligated since award; $721K in FY2021–FY2025 actions
Click a bar to open its office page.
Insight National Institutes of Health placed 100%.
Contracting offices that awarded Murty Pharmaceuticals prime contracts, FY2021–FY2026
See which offices award its contracts.
1 office awarded only one contract.
Showing 1–2 of 2 offices
| Contracts active FY2021–FY2026; obligated since award, US$ | |||||
|---|---|---|---|---|---|
| NATIONAL INSTITUTES OF HEALTH NIDA (75N950) | National Institutes of Health | 8 | $2,711,409 | Sep 16, 2016 | Aug 26, 2025 |
| NATIONAL INSTITUTES OF HEALTH OLAO (75N980) | National Institutes of Health | 1 | $92,724 | Aug 25, 2026 | Aug 25, 2026 |
Opportunities
Open opportunities matching Murty Pharmaceuticals, Inc.'s registered industries
Notices in its 2 industries (NAICSNAICS code: a six-digit code for the kind of work a company does. Each contract carries one, and it sets the small-business size limit. Glossary): 325412, 325411
8 of the next 10 are due within 30 days.
Showing 1–10 of 10 opportunities
| Opportunity | Agency | Due |
|---|---|---|
| 6505--Sodium Bicarbonate Injection Vial Restricted to Made in America (opens in Procura)Presolicitation · NAICS 325412Free account: full notice, dates, attachments | Department of Veterans AffairsNAC PHARMACEUTICALS (36E797) | Oct 21, 2026 |
| Inhaled Nitric Oxide (opens in Procura)Sources Sought · NAICS 325412Free account: full notice, dates, attachments | Defense Health Agency (DOD)DEFENSE HEALTH AGENCY (HT9408) | Oct 22, 2026 |
| Methylphenidate ER (opens in Procura)Solicitation · NAICS 325412Free account: full notice, dates, attachments | Defense Logistics Agency (DOD)DLA TROOP SUPPORT (SPE2D2) | Oct 23, 2026 |
| Department of War Pharmacy Uniform Formulary Blanket Purchase Agreement / Uniform Formulary Additional Discount Program (opens in Procura)Solicitation · NAICS 325412Free account: full notice, dates, attachments | Defense Health Agency (DOD)DEFENSE HEALTH AGENCY (DHA) (HT0040) | Oct 26, 2026 |
| 6505--Imatinib Tablets (opens in Procura)Solicitation · NAICS 325412Free account: full notice, dates, attachments | Department of Veterans AffairsNAC PHARMACEUTICALS (36E797) | Oct 30, 2026 |
| 6505--FY27 Low Energy General Radiopharmaceuticals 36C25027Q0052 (opens in Procura)Sources Sought · NAICS 325412Free account: full notice, dates, attachments | Department of Veterans Affairs250-NETWORK CONTRACT OFFICE 10 (36C250) | Nov 3, 2026 |
| LIDOCAINE 5% PATCHES-REQUEST FOR INFORMATION (opens in Procura)Sources Sought · NAICS 325412Free account: full notice, dates, attachments | Department of Veterans AffairsNATIONAL CMOP OFFICE (36C770) | Nov 3, 2026 |
| Epinephrine Injector (opens in Procura)Solicitation · NAICS 325412Free account: full notice, dates, attachments | Defense Logistics Agency (DOD)DLA TROOP SUPPORT (SPE2D2) | Nov 16, 2026 |
| 6505--Department of Veterans Affairs Pharmaceutical Industry Day (opens in Procura)Special Notice · NAICS 325412Free account: full notice, dates, attachments | Department of Veterans AffairsNAC FEDERAL SUPPLY SCHEDULE (36F797) | Nov 20, 2026 |
| TECHNOLOGY LICENSING OPPORTUNITY: Clathrate Therapeutics Platform (opens in Procura)Special Notice · NAICS 325412Free account: full notice, dates, attachments | Department of EnergyOffice 899015 | Dec 4, 2026 |
Registration and contacts
Registration
- UEI
- DNJBTJ3XBQM6
- CAGE code
- 3BJ06
- Registration
- Active, expires Feb 23, 2027
- Entity type
- Corporate Entity (Not Tax Exempt)
- Location
- LEXINGTON, KY, 40509
- Congressional district
- KY-06
- Established
- 1995
Registered industries (NAICSNAICS code: a six-digit code for the kind of work a company does. Each contract carries one, and it sets the small-business size limit. Glossary)
Registered in 2 industries; primary 325412
Contacts at Murty Pharmaceuticals, Inc.
| Contact | Role | As of |
|---|---|---|
| See contactsLocked · 7-day trial or paid plan (name, title and contact details with a 7-day trial or paid plan) | Government business POC · Electronic business POC · Company contact · Past performance POCSAM.gov registrationSBA profileAs of Oct 4, 2026 | Oct 4, 2026 |
| See contactsLocked · 7-day trial or paid plan (name, title and contact details with a 7-day trial or paid plan) | Alternate government business POC · Alternate electronic business POC · Alternate past performance POCSAM.gov registrationAs of Feb 25, 2026 | Feb 25, 2026 |
Correct this listing
Tell us what to correct or add on the Murty Pharmaceuticals, Inc. page. We check every request before we change a profile.